ArticleJournal of nanobiotechnology2024

CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination.

Yunshu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.